Saint-Gobain Life Sciences announced today that it is acquiring MS Techniques and Transluminal to expand its medical components capabilities.
Pompey, France-based MS Techniques, a 137-person company, offers experience in high-precision thermoplastic extrusion and design expertise for minimally invasive catheter solutions centered around the cardiovascular market, according to a news release.
Transluminal designs, develops and manufactures medical devices for transluminal therapies, according to the company’s website.
Saint-Gobain Life Sciences plans to integrate both companies into its medical components business unit, saying the new acquisitions are very similar with customized, co-development models and similar corporate cultures that it hopes to build upon.
“We are looking forward to welcoming MS Techniques and Transluminal to the Saint-Gobain Medical family,” Saint-Gobain GM of medical components & electronics John Schmitz said in the release. “Aligning with our growth strategy, they strengthen our presence in Europe, broaden our precision extrusion capabilities and catheter design expertise, helping us further expand into the interventional and minimally invasive market.”
“We decided to join forces with Saint-Gobain because we felt we found a true partnership and shared the same vision: to become a world-class reference in the medical device industry for delivering minimally invasive innovation,” MS Techniques president Etienne Malher added. “Joining a global medical organization with the size and tremendous legacy of Saint-Gobain makes it possible to carry forward what we have worked so hard to build over the last 28 years.
“With more resources and the Saint-Gobain brand supporting our efforts, we pave the way for future innovation and the co-development of new medical solutions with our customers.”